Clinical Trial

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

Study acronym: BUDS-HF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to analyze the utility of a novel five-point ultrasound as a predictor of volume overload in diverse patients who are admitted with volume overload/congestive heart failure (CHF) exacerbation at Boston Medical Center (BMC), the largest safety-net hospital in New England. Current standard of care (SOC) involves the utilization of laboratory markers and physical exam, which is often inconsistent and equivocal. The investigators will assess will assess if ultrasound-assisted diuresis reduces recurrent episodes of volume overload/decompensated heart failure.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-10 -> 2027-12 2026-07-01
minor Completion pushed: 2027-10 -> 2027-12 2026-07-01
Trial Details
NCT Number NCT07096726
Lead Sponsor Boston Medical Center
Conditions Congestive Heart Failure, Volume Overload
Enrollment 200 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-30